COVID-19 diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
==Diagnostic Study of Choice== | ==Diagnostic Study of Choice== | ||
{| class="wikitable" | |||
|+ | |||
!Case | |||
!Diagnostic Criteria | |||
|- | |||
!Suspected Case | |||
|Anyone with a history of epidemiology and any two of the clinical manifestations or anyone without epidemiological history and three of the clinical manifestations is considered to be a suspected case: | |||
|- | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
|} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 13:55, 16 March 2020
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19 diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of COVID-19 diagnostic study of choice |
|
Risk calculators and risk factors for COVID-19 diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Carla Vorsatz, M.D.[2]
Overview
Diagnostic Study of Choice
| Case | Diagnostic Criteria |
|---|---|
| Suspected Case | Anyone with a history of epidemiology and any two of the clinical manifestations or anyone without epidemiological history and three of the clinical manifestations is considered to be a suspected case: |